1. Severe COVID-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study
- Author
-
Jan Gojda, Kateřina Koudelková, Anna Ouřadová, Alexander Lang, Magdaléna Krbcová, Alexandra Gvozdeva, Viktor Šebo, Lotte Slagmolen, Jana Potočková, Petr Tůma, Lenka Rossmeislová, Michal Anděl, Fredrik Karpe, and Sabrina Schlesinger
- Subjects
Nutritional diseases. Deficiency diseases ,RC620-627 - Abstract
Abstract Background COVID-19, an infectious disease caused by SARS-CoV-2, was shown to be associated with an increased risk of new-onset diabetes. Mechanisms contributing to the development of hyperglycemia are still unclear. We aimed to study whether hyperglycemia is related to insulin resistance and/or beta cell dysfunction. Materials and methods Survivors of severe COVID-19 but without a known history of diabetes were examined at baseline (T0) and after 3 (T3) and 6 (T6) months: corticosteroids use, indirect calorimetry, and OGTT. Insulin response and sensitivity (IS) were expressed as insulinogenic (IGI), disposition (DI), and Matsuda insulin sensitivity index (ISI). Resting energy expenditure (REE) and respiratory quotient (RQ) was calculated from the gas exchange and nitrogen losses. Results 26 patients (out of 37) with complete outcome data were included in the analysis (age ~59.0 years; BMI ~ 30.4, 35% women). Patients were hypermetabolic at T0 (30.3 ± 4.0 kcal/kg lean mass/day, ~120% predicted) but REE declined over 6 months (ΔT6-T0 mean dif. T6-T0 (95% CI): −5.4 (−6.8, −4.1) kcal/kg FFM/day, p
- Published
- 2023
- Full Text
- View/download PDF